Bryan Riggsbee News Today

CareDx Inc. announced that Bryan Riggsbee joins CareDx?s Board of Directors, effective March 11, 2024. Riggsbee previously served as Chief Financial Officer at Myriad Genetics, where he made...

In a notable shift, CFOs like Bryan Riggsbee of Myriad Genetics are opting for equity over debt as central banks hike interest rates.

For the first time in a long while, it’s cheaper for some companies in the U.S. to sell shares than to borrow in the debt markets. Read more

Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) shares shot up 2.7% on Thursday . The company traded as high as $18.76 and last traded at $18.73. 139,980 shares were traded during mid-day trading, a decline of 73% from the average session volume of 523,469 shares. The stock had previously closed at $18.24. Wall Street […]

Piper Sandler initiated coverage on shares of Myriad Genetics (NASDAQ:MYGN – Free Report) in a research note released on Thursday morning, Benzinga reports. The firm issued a neutral rating and a $23.00 price target on the stock. A number of other analysts have also weighed in on MYGN. StockNews.com upgraded shares of Myriad Genetics from […]

Myriad Genetics (NASDAQ:MYGN – Get Free Report) issued an update on its FY 2023 earnings guidance on Thursday morning. The company provided EPS guidance of -0.330–0.280 for the period, compared to the consensus EPS estimate of -0.300. The company issued revenue guidance of $747.0 million-$753.0 million, compared to the consensus revenue estimate of $750.9 million. […]

Myriad Genetics (NASDAQ:MYGN – Get Free Report) issued an update on its FY 2023 earnings guidance on Thursday morning. The company provided EPS guidance of -0.330–0.280 for the period, compared to the consensus EPS estimate of -0.300. The company issued revenue guidance of $747.0 million-$753.0 million, compared to the consensus revenue estimate of $750.9 million. […]

SALT LAKE CITY, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today...

SALT LAKE CITY, Dec. 21, 2023 -- Myriad Genetics, Inc., , a leader in genetic testing and precision medicine, today announced the appointment of Scott Leffler as Chief Financial Officer , effective...

Artisan Partners Limited Partnership increased its position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 15.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,538,065 shares of the company’s stock after purchasing an additional 331,207 shares during the […]